相关实验视频
Updated: Jul 25, 2025

16:24
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
20.3K
转录调节的miR-26a-5p可能会在三阴性乳腺癌中充当BRCAness
Yue Zhang1, Lianqiu Lv1, Renjing Zheng1
1Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Breast cancer research : BCR
|June 26, 2023
概括
在三阴性乳腺癌 (TNBC) 中下调的MicroRNA-26a-5p通过增加DNA损伤和促进亡来增强化疗敏感性. 恢复miR-26a-5p表达可能是TNBC的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 三重阴性乳腺癌 (TNBC) 的预后不佳,治疗选择有限.
- 在TNBC中,DNA损伤和修复途径是关键的治疗点.
- 微RNA正在成为癌症治疗中的关键调节剂.
研究的目的:
- 调查miR-26a-5p在增强TNBC中化疗敏感性的作用.
- 探索miR-26a-5p是否可以诱导BRCAness表型并改善对化疗的反应.
- 阐明miR-26a-5p通过哪些机制影响TNBC中的DNA损伤,亡和药物敏感性.
主要方法:
- 定量逆转录聚合酶连锁反应 (RT-qPCR) 用于miR-26a-5p表达分析.
- 细胞活力测定 (CCK-8),彗星测定DNA损伤,和流细胞测量对细胞亡.
- 西方斑点,免疫光和光酶记者测定用于分子机制研究.
- 激素剥夺/刺激测定和染色体免疫沉 (ChIP) 来评估激素受体调节.
- 在体内动物实验中评估miR-26a-5p的治疗效果.
主要成果:
- 在TNBC组织和细胞系中,miR-26a-5p的表达显著下调.
- 过度表达miR-26a-5p增强了西斯胺诱导的DNA损伤,亡和TNBC细胞的敏感性.
- miR-26a-5p促进了Fas表达,导致对死亡受体亡的过敏.
- miR-26a-5p对BARD1和NABP1进行负调节,诱导同源重组修复缺陷 (HRD).
- miR-26a-5p增强了对Olaparib的敏感性和对西斯普拉丁和Olaparib的联合治疗.
- 激素受体 (ER-a,PR) 作为调节miR-26a-5p表达的转录因子.
结论:
- 在TNBC中,miR-26a-5p在调节思丁敏感性方面起着至关重要的作用.
- miR-26a-5p通过涉及DNA损伤和合成致命性的机制提高化疗疗效.
- 恢复miR-26a-5p代表了改善TNBC治疗结果的潜在治疗策略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Master Transcription Regulators
7.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
Regulation of Expression at Multiple Steps
951
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
951
Co-activators and Co-repressors
7.4K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K

